Plans scrapped for Xadago trial for levodopa-induced dyskinesia
PARKINSON'S NEWS TODAY,
Newron Pharmaceuticals and Zambon Pharma have ended their plans to run a clinical trial to test Xadago (safinamide) for…
Newron Pharmaceuticals and Zambon Pharma have ended their plans to run a clinical trial to test Xadago (safinamide) for…
Parkinson’s disease (PD) is a common neurodegenerative disease, the pathological features of which include the presence of Lewy…